Genomics of body weight regulation: Unraveling the molecular mechanisms predisposing to obesity;Genómica de la regulación del peso corporal: Mecanismos moleculares que predisponen a la obesidad

Medicina Clinica

Volumn 123, Issue 3, 2004, Pages 104-117

  Bastarrachea, Raúl A ^a   Cole, Shelley A ^a   Comuzzie, Anthony G ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Beacon; Genetics; Genome scan; Linkage; Obesity; Quantitative trait loci (QTLs); Tanis

Indexed keywords

BODY WEIGHT; DISEASE PREDISPOSITION; ENERGY EXPENDITURE; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC RISK; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HOMEOSTASIS; HUMAN; METABOLIC DISORDER; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PEDIGREE; POPULATION RESEARCH; QUANTITATIVE TRAIT LOCUS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 3142732848     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13063474     Document Type: Review

References (194)

1. Pastor P, Makuk DM, Reuben C, Xia H. Chartbook on trends in the health of Americans. Health, United States, 2002. Hyattsville National Center for Health Statistics, 2002.
2. International Obesity Task Force 2003. Disponible en: http://www.obesite.chaire.ulaval.ca/iotf.htm
3. Seidell JC. Prevalence and time trend of obesity in Europe. J Endocrinol 2002;25:816-22.
4. Popkin BM, Lu B, Zhai F. Understanding the nutrition transition: measuring rapid dietary changes in transitional countries. Public Health Nutr 2002;5(Suppl 6A):947-53.
5. Caballero B. Introduction. Symposium: Obesity in developing countries: biological and ecological factors. J Nutr 2001;131:866S-70S.
6. Comuzzie AG, Williams JT, Martin LJ, Blangero J. Searching for genes underlying normal variation in human adiposity. J Mol Med 2001;79: 57-70.
7. French SA, Story M, Jeffery RW. Environmental influences on eating and physical activity. Annu Rev Public Health 2001;22:309-35.
8. Loos RJ, Bouchard C. Obesity - is it a genetic disorder? J Intern Med 2003;54:401-25.
9. Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998;280:1374-7.
10. Chagnon YC, Rankinen T, Snyder EE, Weisnagel SJ, Perusse L, Bouchard C. The human obesity gene map: the 2002 update. Obes Res 2003;11:313-67.
11. Lindsay RS, Bennett PH. Type 2 diabetes, the thrifty phenotype - an overview. Br Med Bull 2001;60:21-32.
12. Zhao Z, Fu YX, Hewett-Emmett D, Boerwinkle E. Investigating single nucleotide polymorphism (SNP) density in the human genome and its implications for molecular evolution. Gene 2003;312:207-13.
13. Kagawa Y, Yanagisawa Y, Hasegawa K, Suzuki H, Yasuda K, Kudo H, et al. Single nucleotide polymorphisms of thrifty genes for energy metabolism: evolutionary origins and prospects for intervention to prevent obesity-related diseases. Biochem Biophys Res Commun 2002;295: 207-22.
14. Bauman WA. Hibernation: a model of adaptive hyperlipogenesis and associated metabolic features. En: Bjorntorp P, Brodoff B, editors. Obesity. Philadelphia: JB Lippincott, 1992; p. 206-19.
15. Pond CM. An evolutionary and functional view of mammalian adipose tissue. Proc Nutr Soc 1992;51:367-77.
16. Cinti S. The adipose organ: morphological perspectives of adipose tissues. Proc Nutr Soc 2001;60:319-28.
17. Kawada T, Takahashi N, Fushiki T. Biochemical and physiological characteristics of fat cell. J Nutr Sci Vitaminol (Tokyo) 2001;47:1-12.
18. Neel JV. Diabetes mellitus: a «thrifty» genotype rendered detrimental by «progress»? Bull World Health Organ 1999;77:694-703 [discussion, 692-3].
19. Neel JV. The «thrifty genotype» in 1998. Nutr Rev 1999;57:S2-S9.
20. Rolls BJ, Hammer VA. Fat, carbohydrate, and the regulation of energy intake. Am J Clin Nutr 1995;62:1086S-95S.
21. Stubbs RJ, Mazlan N, Whybrow S. Carbohydrates, appetite and feeding behavior in humans. J Nutr 2001;131:2775S-81S.
22. Lieberman LS. Dietary, evolutionary, and modernizing influences on the prevalence of type 2 diabetes. Annu Rev Nutr 2003;23:345-77.
23. Myslobodsky M. Gourmand savants and environmental determinants of obesity. Obes Rev 2003;4:121-8.
24. Poston WS II, Foreyt JP. Obesity is an environmental issue. Atherosclerosis 1999;146:201-9.
25. Clement K, Boutin P, Froguel P. Genetics of obesity. Am J Pharmacogenomics 2002;2:177-87.
26. Arner P. Obesity-a genetic disease of adipose tissue? Br J Nutr 2000; 83(Suppl 1):9-16.
27. Shuldiner AR, Munir KM. Genetics of obesity: more complicated than initially thought. Lipids 2003;38:97-101.
28. Liu YJ, Araujo S, Recker RR, Deng HW. Molecular and genetic mechanisms of obesity: implications for future management. Curr Mol Med 2003;3:325-40.
29. Stunkard AJ, Sorensen TI, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, et al. An adoption study of human obesity. N Engl J Med 1986;314:193-8.
30. Fabsitz RR, Carmelli D, Hewitt JK. Evidence for independent genetic influences on obesity in middle age. Int J Obes Relat Metab Disord. 1992;16:657-66.
31. Comuzzie AG, Blangero J, Mahaney MC, Haffner SM, Mitchell BD, Stern MP, et al. Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography. J Clin Endocrinol Metab 1996;81:597-600.
32. Kaprio J, Eriksson J, Lehtovirta M, Koskenvuo M, Tuomilehto J. Heritability of leptin levels and the shared genetic effects on body mass index and leptin in adult Finnish twins. Int J Obes Relat Metab Disord. 2001; 25:132-7.
33. Schousboe K, Willemsen G, Kyvik KO, Mortensen J, Boomsma DI, Cornes BK, et al. Sex differences in heritability of BMI: a comparative study of results from twin studies in eight countries. Twin Res 2003;6: 409-21.
34. Coady SA, Jaquish CE, Fabsitz RR, Larson MG, Cupples LA, Myers RH. Genetic variability of adult body mass index: a longitudinal assessment in Framingham families. Obes Res 2002;10:675-81.
35. Lee JH, Reed DR, Price RA. Familial risk ratios for extreme obesity: implications for mapping human obesity genes. Int J Obes Relat Metab Disord 1997;21:935-40.
36. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997;27:325-51.
37. Vogler GP, Sorensen TI, Stunkard AJ, Srinivasan MR, Rao DC. Influences of genes and shared family environment on adult body mass index assessed in an adoption study by a comprehensive path model. Int J Obes Relat Metab Disord 1995;19:40-5.
38. Borecki IB, Higgins M, Schreiner PJ, Arnett DK, Mayer-Davis E, Hunt SC, et al. Evidence for multiple determinants of the body mass index: the National Heart, Lung, and Blood Institute Family Heart Study. Obes Res 1998;6:107-14.
39. Rice T, Perusse L, Bouchard C, Rao DC. Familial aggregation of body mass index and subcutaneous fat measures in the longitudinal Quebec family study. Genet Epidemiol 1999;16:316-34.
40. Hsueh WC, Mitchell BD, Schneider JL, St Jean PL, Pollin TI, Ehm MG, et al. Genome-wide scan of obesity in the Old Order Amish. J Clin Endocrinol Metab 2001;86:1199-205.
41. Comuzzie AG, Blangero J, Mahaney MC, Mitchell BD, Hixson JE, Samollow PB, et al. Major gene with sex-specific effects influences fat mass in Mexican Americans. Genet Epidemiol 1995;12:475-88.
42. Rose KM, Newman B, Mayer-Davis EJ, Selby JV. Genetic and behavioral determinants of waist-hip ratio and waist circumference in women twins. Obes Res 1998;6:383-92.
43. Nelson TL, Brandon DT, Wiggins SA, Whitfield KE. Genetic and environmental influences on body-fat measures among African-American twins. Obes Res 2002;10:733-9.
44. Nelson TL, Vogler GP, Pedersen NL, Miles TP. Genetic and environmental influences on waist-to-hip ratio and waist circumference in an older Swedish twin population. Int J Obes Relat Metab Disord 1999;23:449-55.
45. Hunt MS, Katzmarzyk PT, Perusse L, Rice T, Rao DC, Bouchard C. Familial resemblance of 7-year changes in body mass and adiposity. Obes Res 2002;10:507-17.
46. Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997;15:273-6.
47. Walder K, Hanson RL, Kobes S, Knowler WC, Ravussin E. An autosomal genomic scan for loci linked to plasma leptin concentration in Pima Indians. Int J Obes Relat Metab Disord 2000;24:559-65.
48. Hixson JE, Almasy L, Cole S, Birnbaum S, Mitchell BD, Mahaney MC, et al. Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab 1999;84:3187-91.
49. Pagani F, Buratti E, Stuani C, Baralle FE. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J Biol Chem 2003; 278:26580-8.
50. Broeckel U, Schork NJ. Identifying genes and genetic variation underlying human diseases and complex phenotypes via recombination mapping. J Physiol 20041;554(Pt 1):40-5.
51. Rankinen T, Perusse L, Weisnagel SJ, Snyder EE, Chagnon YC, Bouchard C. The human obesity gene map: the 2001 update. Obes Res 2002;10:196-243.
52. Walder K, Segal D, Jowett J, Blangero J, Collier GR. Obesity and diabetes gene discovery approaches. Curr Pharm Des 2003;9:1357-72.
53. Rogers J, Mahaney MC, Almasy L, Comuzzie AG, Blangero J. Quantitative trait linkage mapping in anthropology. Am J Phys Anthropol 1999(Suppl 29):127-51.
54. McPherson JD, Marra M, Hillier L, Waterston RH, Chinwalla A, Wallis J, et al. A physical map of the human genome. Nature 2001;409:934-41.
55. Wiltshire S, Cardon LR, McCarthy MI. Evaluating the results of genome-wide linkage scans of complex traits by locus counting. Am J Hum Genet 2002;71:1175-82.
56. Wille A, Leal SM. Novel selection criteria for genome scans of complex traits. Genet Epidemiol 2001;21(Suppl 1):800-4.
57. Blangero J, Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol 1997;14:959-64.
58. Blangero J, Williams JT, Almasy L. Robust LOD scores for variance component-based linkage analysis. Genet Epidemioi 2000;19(Suppl 1):8-14.
59. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science 2001;291:1304-51.
60. Comuzzie AG. The emerging pattern of the genetic contribution to human obesity. Best Pract Res Clin Endocrinol Metab 2002;16:611-21.
61. Brockmann GA, Bevova MR. Using mouse models to dissect the genetics of obesity. Trends Genet 2002;18:367-76.
62. Sorensen TI, Echwald SM. Obesity genes. BMJ 2001;322:630-1.
63. Robinson SW, Dinulescu DM, Cone RD. Genetic models of obesity and energy balance in the mouse. Annu Rev Genet 2000;34:687-745.
64. Barsh GS, Farooqi IS, O'Rahilly S. Genetics of body-weight regulation. Nature 2000;404:644-51.
65. Echwald SM. Genetics of human obesity: lessons from mouse models and candidate genes. J Intern Med 1999;245:653-66.
66. Miller MW, Duhl DM, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, et al. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev 1993;7:454-67.
67. Miller KA, Gunn TM, Carrasquillo MM, Lamoreux ML, Galbraith DB, Barsh GS. Genetic studies of the mouse mutations mahogany and mahoganoid. Genetics 1997;146:1407-15.
68. He L, Eldridge AG, Jackson PK, Gunn TM, Barsh GS. Accessory proteins for melanocortin signaling: attractin and mahogunin. Ann N Y Acad Sci 2003;994:288-98.
69. Barsh GS, He L, Gunn TM. Genetic and biochemical studies of the Agouti-attractin system. Recept Signal Transduct Res 2002;22:63-77.
70. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
71. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996;84: 491-5.
72. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-71.
73. Cawley NX, Rodriguez YM, Maldonado A, Loh YP. Trafficking of mutant carboxypeptidase E to secretory granules in a beta-cell line derived from Cpe(fat)/Cpe(fat) mice. Endocrinology 2003;144:292-8.
74. Jackson RS, Creemers JW, Farooqi IS, Raffin-Sanson ML, Varro A, Dockray GJ, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003;112:1550-60.
75. Santagata S, Boggon TJ, Baird CL, Gómez CA, Zhao J, Shan WS, et al. G-protein signaling through tubby proteins. Science 2001;292:2041-50.
76. Ikeda A, Naggert JK, Nishina PM. Genetic modification of retinal degeneration in tubby mice. Exp Eye Res 2002;74:455-61.
77. Pomp D. Animal models of obesity. Mol Med Today 1999;5:459-60.
78. Augustine KA, Rossi RM. Rodent mutant models of obesity and their correlations to human obesity. Anat Rec 1999;257:64-72.
79. Diament AL, Fisler JS, Warden CH. Studies of natural allele effects in mice can be used to identify genes causing common human obesity. Obes Rev 2003;4:249-55.
80. Inui A. Obesity-a chronic health problem in cloned mice? Trends Pharmacol Sci 2003;24:77-80.
81. Pomp D. Genetic dissection of obesity in polygenic animal models. Behav Genet 1997;27:285-306.
82. Moody DE, Pomp D, Nielsen MK, Van Vleck LD. Identification of quantitative trait loci influencing traits related to energy balance in selection and inbred lines of mice. Genetics 1999;152:699-711.
83. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002;8:731-7.
84. West DB, Waguespack J, McCollister S. Dietary obesity in the mouse: interaction of strain with diet composition. Am J Physiol 1995;268: R658-R65.
85. Smith BK, Andrews PK, West DB. Macronutrient diet selection in thirteen mouse strains. Am J Physiol Regul Integr Comp Physiol 2000;278: R797-R805.
86. Paigen B. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am J Clin Nutr 1995;62:458S-62S.
87. Smith Richards BK, Belton BN, Poole AC, Mancuso JJ, Churchill GA, Li R, et al. QTL analysis of self-selected macronutrient diet intake: fat, carbohydrate, and total kilocalories. Physiol Genomics 2002;11:205-17.
88. Warden CH, Fisler JS, Shoemaker SM, Wen PZ, Svenson KL, Pace MJ, et al. Identification of four chromosomal loci determining obesity in a multifactorial mouse model. J Clin Invest 1995;95:1545-52.
89. York B, Truett AA, Monteiro MP, Barry SJ, Warden CH, Naggert JK, et al. Gene-environment interaction: a significant diet-dependent obesity locus demonstrated in a congenic segment on mouse chromosome 7. Mamm Genome 1999;10:457-62.
90. Livingston JN. Genetically engineered mice in drug development. J Intern Med 1999;245:627-35.
91. Mauvais-Jarvis F, Kulkarni RN, Kahn CR. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin Endocrinol (Oxf) 2002;57:1-9.
92. Lee K, Villena JA, Moon YS, Kim KH, Lee S, Kang C, et al. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 2003;111:453-61.
93. Fridman C, Varela MC, Kok F, Setian N, Koiffmann CP. Prader-Willi syndrome: genetic tests and clinical findings. Genet Test 2000;4:387-92.
94. Nativio DG. The genetics, diagnosis, and management of Prader-Willi syndrome. J Pediatr Health Care 2002;16:298-303.
95. Gallagher RC, Pils B, Albalwi M, Francke U. Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet 2002;71:669-78.
96. Katsanis N, Lupski JR, Beales PL. Exploring the molecular basis of Bardet-Biedl syndrome. Hum Mol Genet 2001;10:2293-9.
97. Nishimura DY, Searby CC, Carmi R, Elbedour K, Van Maldergem L, Fulton AB, et al. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet 2001;10: 865-74.
98. Mykytyn K, Braun T, Carmi R, Haider NB, Searby CC, Shastri M, et al. Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet 2001;28:188-91.
99. Slavotinek AM, Stone EM, Mykytyn K, Heckenlively JR, Green JS, Heon E, et al. Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet 2000;26:15-6.
100. Mykytyn K, Nishimura DY, Searby CC, Beck G, Bugge K, Haines HL, et al. Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). Am J Hum Genet 2003;72:429-37.
101. Badano JL, Ansley SJ, Leitch CC, Lewis RA, Lupski JR, Katsanis N. Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. Am J Hum Genet 2003;72:650-8.
102. Reed DR, Ding Y, Xu W, Cather C, Price RA. Human obesity does not segregate with the chromosomal regions of Prader-Willi, Bardet-Biedl, Cohen, Borieson or Wilson-Turner syndromes. Int J Obes Relat Metab Disord 1995;19:599-603.
103. Coleman DL. Diabetes-obesity syndromes in mice. Diabetes 1982; 31(Suppl 1 Pt 2):1-6.
104. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973;9:294-8.
105. Pralong FP, Gaillard RC. Neuroendocrine effects of leptin. Pituitary 2001;4:25-32.
106. Harris RB. Leptin-much more than a satiety signal. Annu Rev Nutr 2000;20:45-75.
107. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Annu Rev Med 2003;54:453-71.
108. Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL. Is the energy homeostasis system inherently biased toward weight gain? Diabetes 2003;52:232-8.
109. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8.
110. Farooqi S, Rau H, Whitehead J, O'Rahilly S. ob gene mutations and human obesity. Proc Nutr Soc 1998;57:471-5.
111. Echwald SM, Rasmussen SB, Sorensen TI, Andersen T, Tybjaerg-Hansen A, Clausen JO, et al. Identification of two novel missense mutations in the human OB gene. Int J Obes Relat Metab Disord 1997;21: 321-6.
112. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, et al. Partial leptin deficiency and human adiposity. Nature 2001;414:34-5.
113. Lloyd RV, Jin L, Tsumanuma I, Vidal S, Kovacs K, Horvath E, et al. Leptin and leptin receptor in anterior pituitary function., Pituitary 2001;4: 33-47.
114. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999;84:3686-95.
115. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110:1093-103.
116. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879-84.
117. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
118. Challis BG, Pritchard LE, Creemers JW, Delplanque J, Keogh JM, Luan J, et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 2002;11:1997-2004.
119. Abdel-Malek ZA. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 2001;58: 434-41.
120. Bjorbaek C, Hollenberg AN. Leptin and melanocortin signaling in the hypothalamus. Vitam Horm 2002;65:281-311.
121. MacNeil DJ, Howard AD, Guan X, Fong TM, Nargund RP, Bednarek MA, et al. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur J Pharmacol 2002;450:93-109.
122. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, Mullis PE, et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003;88:4633-40.
123. Krude H, Biebermann H, Gruters A. Mutations in the human proopiomelanocortin gene. Ann N Y Acad Sci 2003;994:233-9.
124. Wardlaw SL. Clinical review: obesity as a neuroendocrine disease: lessons to be learned from proopiomelanocortin and melanocortin receptor mutations in mice and men. J Clin Endocrinol Metab 2001;86: 1442-6.
125. Hinney A, Schmidt A, Nottebom K, Heibult O, Becker I, Ziegler A, et al. Several mutations in the melanocortin-4 receptor gene including a non-sense and a frameshift mutation associated with dominantly inherited obesity in humans. Clin Endocrinol Metab 1999;84:1483-6.
126. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. Clin Invest 2000;106:253-62.
127. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. Clin Invest 2000;106:271-9.
128. Miraglia del Giudice E, Cirillo G, Nigro V, Santoro N, D'Urso L, Raimondo P, et al. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int J Obes Relat Metab Disord 2002;26:647-51.
129. Kobayashi H, Ogawa Y, Shintani M, Ebihara K, Shimodahira M, Iwakura T, et al. A novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes 2002;51:243-6.
130. Marti A, Corbalan MS, Forga L, Martinez JA, Hinney A, Hebebrand J. A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population. Int J Obes Relat Metab Disord 2003;27:385-8.
131. Jacobson P, Ukkola O, Rankinen T, Snyder EE, Leon AS, Rao DC, et al. Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort. J Clin Endocrinol Metab 2002;87:4442-6.
132. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003;348:1085-95.
133. Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, Horber FF. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003;348:1096-103.
134. Cone RD. Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype? J Clin Invest 2000;106:185-7.
135. Lubrano-Berthelier C, Cavazos M, Le Stunff C, Haas K, Shapiro A, Zhang S et al. The human MC4R promoter: characterization and role in obesity. Diabetes 2003;52:2996-3000.
136. Macho Azcarate T, Martí del Moral A, Martínez Hernández JA. Estudios genéticos de la obesidad en humanos. Med Clin (Barc) 2000;115: 103-10.
137. Krief S, Lonnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, et al. Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 1993;91:344-9.
138. Li LS, Lonnqvist F, Luthman H, Arner P. Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 1996;39:857-60.
139. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H, et al. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 2000;271:212-6.
140. Dionne IJ, Turner AN, Tchernof A, Pollin TI, Avrithi D, Gray D, et al. Identification of an interactive effect of beta3- and alpha2b-adrenoceptor gene polymorphisms on fat mass in Caucasian women. Diabetes 2001;50:91-5.
141. Hsueh WC, Cole SA, Shuldiner AR, Bearner BA, Blangero J, Hixson JE, et al. Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity. Diabetes Care 2001;24:672-7.
142. Crowley V, Vidal-Puig AJ. Mitochondrial uncoupling proteins (UCPs) and obesity. Nutr Metab Cardiovasc Dis. 2001;11:70-5.
143. Cassard-Doulcier AM, Bouillaud F, Chagnon M, Gelly C, Dionne FT, Oppert JM, et al. The Bcl I polymorphism of the human uncoupling protein (ucp) gene is due to a point mutation in the 5′-flanking region. Int J Obes Relat Metab Disord 1996;20:278-9.
144. Clement K, Ruiz J, Cassard-Doulcier AM, Bouillaud F, Ricquier D, Basdevant A, et al. Additive effect of A → G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord 1996;20:1062-6.
145. Shihara N, Yasuda K, Moritani T, Ue H, Uno M, Adachi T, et al. Synergistic effect of polymorphisms of uncoupling protein 1 and beta3-adrenergic receptor genes on autonomic nervous system activity. Int J Obes Relat Metab Disord 2001;25:761-6.
146. Matsushita H, Kurabayashi T, Tomita M, Kato N, Tanaka K. Effects of uncoupling protein 1 and beta3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women. Maturitas 2003;45:39-45.
147. Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP, et al. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. Hum Mol Genet 1998;7:1431-5.
148. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-51.
149. Clement K, Manning BS, Basdevant A, Strosberg AD, Guy-Grand B, Froguel P. Gender effect of the Trp64Arg mutation in the beta 3 adrenergic receptor gene on weight gain in morbid obesity. Diabetes Metab 1997;23:424-7.
150. Oizumi T, Daimon M, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, et al. Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care 2001;24: 1579-83.
151. Gagnon J, Mauriege P, Roy S, Sjostrom D, Chagnon YC, Dionne FT, et al. The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 1996;98:2086-93.
152. Deng HW. Population admixture may appear to mask, change or reverse genetic effects of genes underlying complex traits. Genetics 2001;159:1319-23.
153. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
154. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847-56.
155. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-9.
156. Cooper DN, Nussbaum RL, Krawczak M. Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet 2002;110:207-8.
157. Deng HW, Li J, Recker RR. LOD score exclusion analyses for candidate genes using random population samples. Ann Hum Genet 2001;65: 313-29.
158. Permutt MA, Hattersley AT. Searching for type 2 diabetes genes in the post-genome era. Trends Enclocrinol Metab 2000;11:383-93.
159. Blangero J, Williams JT, Almasy L. Variance component methods for detecting complex trait loci. Adv Genet 2001;42:151-81.
160. Dyer TD, Blangero J, Williams JT, Goring HH, Mahaney MC. The effect of pedigree complexity on quantitative trait linkage analysis. Genet Epidemiol 2001;21(Suppl 1):236-43.
161. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-211.
162. Hager J, Dina C, Francke S, Dubois S, Houari M, Vatin V, et al. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 1998;20:304-8.
163. Rotimi CN, Comuzzie AG, Lowe WL, Luke A, Blangero J, Cooper RS. The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes 1999;48:643-4.
164. Martin LJ, Cole SA, Hixson JE, Mahaney MC, Czerwinski SA, Almasy L et al. Genotype by smoking interaction for leptin levels in the San Antonio Family Heart Study. Genet Epidemiol 2002;22:105-15.
165. Mitchell BD, Cole SA, Comuzzie AG, Almasy L, Blangero J, MacCluer JW, et al. A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor. Diabetes 1999;48:1863-7.
166. Mitchell BD, Cole SA, Comuzzie AG. Amajor quantitative trait locus on chromosome 17 is linked to body mass index in Mexican Americans. Circulation 1889;98(Suppl):459.
167. Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, Black AE, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001;86:4321-5.
168. Heilbronn LK, Smith SR, Ravussin E. The insulin-sensitizing role of the fat derived hormone adiponectin. Curr Pharm Des 2003;9:1411-8.
169. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003; 14:561-6.
170. Vionnet N, Hani El-H, Dupont S, Gallina S, Francke S, Dotte S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000;67: 1470-80.
171. Duggirala R, Almasy L, Blangero J, Jenkinson CP, Arya R, DeFronzo RA, et al. American Diabetes Association GENNID Study Group. Further evidence for a type 2 diabetes susceptibility locus on chromosome 11q. Genet Epidemiol 2003;24:240-2.
172. Stone S, Abkevich V, Hunt SC, Gutin A, Russell DL, Neff CD, et al. A major predisposition locus for severe obesity, at 4p15-p14. Am J Hum Genet 2002;70:1459-68.
173. Syvanen AC. Accessing genetic variation: genotyping single nucleotide polymorphisms. Nat Rev Genet 2001;2:930-42.
174. Deng HW, Chen WM, Recker RR. QTL fine mapping by measuring and testing for Hardy-Weinberg and linkage disequilibrium at a series of linked marker loci in extreme samples of populations. Am J Hum Genet 2000;66:1027-45.
175. Bahring S, Aydin A, Luft FC. The study of gene polymorphisms How complex is complex genetic disease? Methods Mol Med 2003;86:221-35.
176. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 1999;22:139-44.
177. Jorde LB. Linkage disequilibrium and the search for complex disease genes. Genome Res 2000;10:1435-44.
178. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
179. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001; 29:229-32.
180. Cardon LR, Abecasis GR. Using haplotype blocks to map human complex trait loci. Trends Genet 2003;19:135-40.
181. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-75.
182. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, et al. Linkage disequilibrium in the human genome. Nature 2001;411:199-204.
183. Abecasis GR, Noguchi E, Heinzmann A, Traherne JA, Bhattacharyya S, Leaves NI, et al. Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet 2001;68:191-7.
184. Couzin J. Genomics. New mapping project splits the community. Science 2002:296:1391-3.
185. Cox LA, Birnbaum S, VandeBerg JL. Identification of candidate genes regulating HDL cholesterol using a chromosomal region expression array. Genome Res 2002;12:1693-702.
186. Burgess JK. Gene expression studies using microarrays. Clin Exp Pharmacol Physiol 2001;28:321-8.
187. Walder KR, Fahey RP, Morton GJ, Zimmet PZ, Collier GR. Characterization of obesity phenotypes in Psammomys obesus (Israeli sand rats). Int J Exp Diabetes Res 2000;1:177-84.
188. Walder K, Kantham L, McMillan JS, Trevaskis J, Kerr L, De Silva A, et al. Tanis: a link between type 2 diabetes and inflammation? Diabetes 2002;51:1859-66.
189. Gao Y, Walder K, Sunderland T, Kantham L, Feng HC, Quick M, et al. Elevation in Tanis expression alters glucose metabolism and insulin sensitivity in H411E cells. Diabetes 2003;52:929-34.
190. Collier GR, McMillan JS, Windmill K, Walder K, Tenne-Brown J, De Silva A, et al. Beacon: a novel gene involved in the regulation of energy balance. Diabetes 2000;49:1766-71.
191. Sainsbury A, Cooney GJ, Herzog H. Hypothalamic regulation of energy homeostasis. Best Pract Res Clin Endocrinol Metab 2002;16:623-37.
192. Morwessel NJ. The genetic basis of diabetes mellitus. AACN Clin Issues 1998;9:539-54.
193. Cheverud JM, Vaughn TT, Pletscher LS, Peripato AC, Adams ES, Erikson CF, et al. Genetic architecture of adiposity in the cross of LG/J and SM/J inbred mice. Mamm Genome 2001;12:3-12.
194. Walder K, Ziv E, Kalman R, Whitecross K, Shafrir E, Zimmet P, et al. Elevated hypothalamic beacon gene expression in Psammomys obesus prone to develop obesity and type 2 diabetes. Int J Obes Relat Metab Disord 2002;26:605-9.